TORONTO--(BUSINESS WIRE)--SQI Diagnostics Inc. (TSX-Venture: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that effective January 09, 2012, they have granted 35,000 stock options to each of David Williams, Paul Mountain, Peter Lea, Eric Schneider, Saied Nadjafi and Peter Winkley and 100,000 stock options to Claude Ricks. All recipients are members of the Board of Directors.
